Danaher Corporation $DHR Shares Sold by Candriam S.C.A.

09 Nov 2026, 09:05 by Michael Walen · The Markets Daily

Candriam S.C.A. trimmed its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 44.9% in the third quarter, Holdings Channel.com reports. The firm owned 99,618 shares of the conglomerate’s stock after selling 81,234 shares during the quarter. Candriam S.C.A.’s holdings in Danaher were worth $22,151,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Gunderson Capital Management LLC bought a new stake in Danaher during the 3rd quarter worth approximately $765,000. EP Wealth Advisors LLC bought a new stake in shares of Danaher in the 2nd quarter valued at $3,807,000. Frank Rimerman Advisors LLC boosted its stake in shares of Danaher by 181.9% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate’s stock valued at $9,051,000 after purchasing an additional 26,363 shares during the last quarter. Birch Hill Investment Advisors LLC boosted its stake in shares of Danaher by 9.6% in the 3rd quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate’s stock valued at $8,984,000 after purchasing an additional 3,553 shares during the last quarter. Finally, Forbes J M & Co. LLP increased its position in shares of Danaher by 141.6% during the third quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate’s stock worth $947,000 after buying an additional 2,506 shares during the period. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on DHR. Royal Bank Of Canada lifted their target price on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research note on Monday, October 5th. Morgan Stanley upped their price target on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. UBS Group reiterated a “buy” rating and set a $260.00 price target on shares of Danaher in a report on Thursday, October 22nd. JPMorgan Chase & Co. boosted their price objective on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Finally, Robert W. Baird upped their target price on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research report on Thursday, October 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $242.91.

Get Our Latest Analysis on DHR

Danaher Stock Up 0.0%

DHR opened at $230.34 on Monday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a market capitalization of $162.05 billion, a P/E ratio of 37.70, a PEG ratio of 2.89 and a beta of 0.76. The company’s 50-day moving average is $220.27 and its 200 day moving average is $201.60. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.89 EPS. Research analysts expect that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is currently 26.19%.

Insider Activity at Danaher

In related news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This trade represents a 45.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 10.80% of the company’s stock.

Danaher Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.